Skip to Main Content

Paper Details

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
J Pathol Clin Res
0
2024
Author NameAffiliation
Don??t Alp??rSemmelweis University
  • 1 - 1

Datasets

Release 1.2